Amide Local Anesthetic [EPC]

Amide Local Anesthetic [EPC] was reported 87229 times

Drugs of the Amide Local Anesthetic [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 872 0.8211
1 MATERNAL EXPOSURE DURING DELIVERY 381 0.3845
2 INSPIRATORY CAPACITY DECREASED 101 0.3646
3 SLEEP DISORDER THERAPY 67 0.3384
4 DEVICE WIRELESS COMMUNICATION ISSUE 72 0.2780
5 APPENDICOLITH 100 0.2584
6 INFUSION SITE DISCHARGE 453 0.2581
7 ANALGESIC THERAPY 69 0.2150
8 LAGOPHTHALMOS 81 0.1980
9 DRUG THERAPY 66 0.1947
10 DEVICE MAINTENANCE ISSUE 114 0.1939
11 TOXIC ANTERIOR SEGMENT SYNDROME 203 0.1861
12 INFUSION SITE MASS 200 0.1840
13 INFUSION SITE HAEMORRHAGE 578 0.1755
14 FOETAL EXPOSURE DURING DELIVERY 115 0.1696
15 INFUSION SITE NODULE 145 0.1509
16 INFUSION SITE PRURITUS 472 0.1495
17 INFUSION SITE IRRITATION 188 0.1463
18 INFUSION SITE BRUISING 313 0.1448
19 INFUSION SITE SWELLING 882 0.1400
20 METHAEMOGLOBINAEMIA 323 0.1394
21 DEVICE INFUSION ISSUE 330 0.1330
22 INFUSION SITE URTICARIA 89 0.1328
23 INFUSION SITE WARMTH 162 0.1321
24 CAUDA EQUINA SYNDROME 98 0.1276
25 INFUSION SITE PAIN 1579 0.1224
26 INFUSION SITE RASH 166 0.1209
27 INFUSION SITE ERYTHEMA 1020 0.1209
28 INFUSION SITE DISCOMFORT 123 0.1186
29 ANAESTHETIC COMPLICATION 312 0.1161
30 PROCEDURAL HYPOTENSION 96 0.1128
31 INFUSION SITE INDURATION 167 0.1126
32 INFUSION SITE DISCOLOURATION 99 0.1125
33 INFUSION SITE INFLAMMATION 75 0.1062
34 PRODUCT ADHESION ISSUE 3517 0.0983
35 INFUSION SITE INFECTION 201 0.0864
36 ANAESTHETIC COMPLICATION NEUROLOGICAL 78 0.0861
37 INFUSION SITE REACTION 249 0.0833
38 PROCEDURAL NAUSEA 67 0.0832
39 IMPLANT SITE EXTRAVASATION 65 0.0827
40 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 85 0.0800
41 DELAYED RECOVERY FROM ANAESTHESIA 70 0.0738
42 HYPERPARATHYROIDISM SECONDARY 160 0.0638
43 KOUNIS SYNDROME 142 0.0625
44 NEPHROGENIC ANAEMIA 289 0.0623
45 INCORRECT DRUG ADMINISTRATION RATE 247 0.0580
46 INFUSION SITE EXTRAVASATION 351 0.0563
47 MULTIPLE ALLERGIES 439 0.0559
48 HYPERTHERMIA MALIGNANT 83 0.0557
49 HYPERPHOSPHATAEMIA 112 0.0520
50 INSURANCE ISSUE 735 0.0480
51 DEVICE ALARM ISSUE 87 0.0479
52 APPLICATION SITE DISCOMFORT 82 0.0456
53 COMPLEX REGIONAL PAIN SYNDROME 66 0.0447
54 DERMATITIS CONTACT 506 0.0443
55 SEASONAL ALLERGY 621 0.0438
56 VASOPLEGIA SYNDROME 68 0.0414
57 OPHTHALMOPLEGIA 65 0.0412
58 ESSENTIAL HYPERTENSION 74 0.0404
59 PARAPLEGIA 114 0.0395
60 BLOOD PHOSPHORUS INCREASED 106 0.0388
61 REBOUND ACID HYPERSECRETION 115 0.0380
62 PULSELESS ELECTRICAL ACTIVITY 154 0.0368
63 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1938 0.0353
64 CORNEAL OEDEMA 77 0.0343
65 CATHETER SITE PAIN 88 0.0339
66 DEVICE POWER SOURCE ISSUE 94 0.0322
67 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 280 0.0316
68 VENTRICULAR FIBRILLATION 351 0.0316
69 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 104 0.0314
70 CHRONIC SINUSITIS 115 0.0306
71 STRESS CARDIOMYOPATHY 175 0.0301
72 OBSTRUCTION 120 0.0300
73 PULSE ABSENT 142 0.0298
74 RESPIRATORY TRACT INFECTION VIRAL 67 0.0287
75 HYPERCAPNIA 86 0.0285
76 CANCER PAIN 72 0.0281
77 EAR INFECTION 747 0.0280
78 ANAPHYLACTIC SHOCK 722 0.0280
79 APNOEA 216 0.0277
80 SINUSITIS 2821 0.0275
81 END STAGE RENAL DISEASE 494 0.0271
82 VENTRICULAR TACHYCARDIA 447 0.0270
83 PURULENT DISCHARGE 115 0.0269
84 RESPIRATORY TRACT INFECTION 699 0.0268
85 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 161 0.0260
86 LUMBAR SPINAL STENOSIS 76 0.0260
87 POOR VENOUS ACCESS 267 0.0258
88 GENERALISED TONIC-CLONIC SEIZURE 422 0.0255
89 OTITIS MEDIA 84 0.0254
90 RESPIRATORY ACIDOSIS 99 0.0252
91 PRODUCT QUALITY ISSUE 3403 0.0250
92 PRODUCT DISTRIBUTION ISSUE 232 0.0250
93 IRON DEFICIENCY 112 0.0249
94 IMPLANT SITE PAIN 109 0.0244
95 APPLICATION SITE BURN 119 0.0241
96 RESPIRATORY DEPRESSION 295 0.0240
97 UPPER RESPIRATORY TRACT INFECTION 1111 0.0240
98 ARTHRITIS INFECTIVE 110 0.0237
99 VASCULAR DEVICE INFECTION 106 0.0233
100 ARTHRITIS BACTERIAL 95 0.0231
101 SPINAL CORD COMPRESSION 90 0.0231
102 STATUS EPILEPTICUS 260 0.0230
103 AUTONOMIC NERVOUS SYSTEM IMBALANCE 66 0.0226
104 VENTRICULAR HYPOKINESIA 72 0.0224
105 INTERVERTEBRAL DISC DEGENERATION 206 0.0222
106 SKIN ABRASION 105 0.0222
107 HAEMODYNAMIC INSTABILITY 169 0.0222
108 SENSORY LOSS 178 0.0221
109 MENINGITIS ASEPTIC 99 0.0220
110 STREPTOCOCCAL INFECTION 122 0.0219
111 WOUND DEHISCENCE 74 0.0219
112 RHINOVIRUS INFECTION 85 0.0218
113 HYPERAESTHESIA 179 0.0218
114 PRODUCT ADMINISTRATION INTERRUPTED 170 0.0216
115 HYPOPHOSPHATAEMIA 160 0.0216
116 ATELECTASIS 208 0.0215
117 SPINAL OSTEOARTHRITIS 188 0.0214
118 TYPE I HYPERSENSITIVITY 75 0.0213
119 LIVE BIRTH 178 0.0213
120 CARDIOGENIC SHOCK 304 0.0212
121 SINUS TACHYCARDIA 296 0.0208
122 DEAFNESS NEUROSENSORY 68 0.0207
123 AORTIC STENOSIS 72 0.0207
124 GASTROENTERITIS VIRAL 369 0.0204
125 NORMAL NEWBORN 111 0.0204
126 UNRESPONSIVE TO STIMULI 519 0.0201
127 PHARYNGITIS STREPTOCOCCAL 217 0.0200
128 HYPERVOLAEMIA 99 0.0200
129 ANAPHYLACTIC REACTION 1080 0.0195
130 SKIN INFECTION 219 0.0195
131 MYASTHENIA GRAVIS 157 0.0194
132 MYOCLONUS 231 0.0193
133 BUNDLE BRANCH BLOCK LEFT 82 0.0193
134 VENTRICULAR ARRHYTHMIA 70 0.0191
135 HYPOXIA 663 0.0188
136 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 322 0.0188
137 PRE-EXISTING CONDITION IMPROVED 117 0.0187
138 BLOOD URIC ACID INCREASED 108 0.0187
139 MENTAL STATUS CHANGES 515 0.0185
140 TENDERNESS 193 0.0185
141 TOOTH INFECTION 242 0.0183
142 HYPERLIPIDAEMIA 219 0.0183
143 NYSTAGMUS 97 0.0183
144 NEURALGIA 442 0.0182
145 BRADYCARDIA 964 0.0182
146 POST PROCEDURAL COMPLICATION 345 0.0179
147 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 92 0.0179
148 PROCEDURAL COMPLICATION 137 0.0179
149 SKIN LACERATION 192 0.0176
150 CARDIAC ARREST 1455 0.0176
151 BRONCHITIS 1292 0.0174
152 PROCTALGIA 112 0.0174
153 ANHEDONIA 456 0.0173
154 VENTRICULAR EXTRASYSTOLES 179 0.0172
155 SINUS DISORDER 340 0.0172
156 GLUCOSE TOLERANCE IMPAIRED 101 0.0171
157 RENAL INJURY 506 0.0170
158 GASTROINTESTINAL INFECTION 152 0.0169
159 DECUBITUS ULCER 138 0.0169
160 APPENDICITIS 158 0.0169
161 NERVE INJURY 188 0.0169
162 SPINAL COLUMN STENOSIS 79 0.0167
163 HORDEOLUM 72 0.0166
164 BACTERIAL INFECTION 308 0.0165
165 INADEQUATE ANALGESIA 140 0.0165
166 BRONCHIECTASIS 111 0.0165
167 EYE INFECTION 184 0.0163
168 ABSCESS LIMB 69 0.0162
169 SINUS BRADYCARDIA 156 0.0161
170 INTERVERTEBRAL DISC DISORDER 68 0.0159
171 NEUROTOXICITY 279 0.0159
172 CHRONIC KIDNEY DISEASE 1206 0.0159
173 DEVICE FAILURE 241 0.0158
174 DEVICE OCCLUSION 221 0.0157
175 WEIGHT FLUCTUATION 164 0.0157
176 THERMAL BURN 111 0.0156
177 WRONG PRODUCT ADMINISTERED 105 0.0155
178 MYDRIASIS 199 0.0155
179 KIDNEY INFECTION 304 0.0155
180 PERONEAL NERVE PALSY 88 0.0155
181 SKIN NECROSIS 80 0.0154
182 RESPIRATORY SYNCYTIAL VIRUS INFECTION 134 0.0154
183 VIRAL INFECTION 511 0.0153
184 HYPOAESTHESIA ORAL 230 0.0152
185 POSTOPERATIVE WOUND INFECTION 103 0.0152
186 STAPHYLOCOCCAL INFECTION 502 0.0152
187 PSEUDOMONAS INFECTION 130 0.0151
188 TOOTH ABSCESS 154 0.0151
189 CIRCULATORY COLLAPSE 257 0.0151
190 BRONCHOSPASM 215 0.0151
191 FEAR 403 0.0150
192 MULTI-ORGAN FAILURE 258 0.0149
193 ACUTE RESPIRATORY FAILURE 283 0.0147
194 ENDOPHTHALMITIS 88 0.0147
195 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 74 0.0146
196 LOW BIRTH WEIGHT BABY 116 0.0146
197 FOOD POISONING 78 0.0145
198 PERIPHERAL VASCULAR DISORDER 75 0.0145
199 POST PROCEDURAL INFECTION 118 0.0145
200 EXOSTOSIS 132 0.0144
201 MENINGITIS 96 0.0144
202 BODY HEIGHT DECREASED 153 0.0143
203 FOOD ALLERGY 110 0.0142
204 RIB FRACTURE 290 0.0141
205 APPLICATION SITE VESICLES 91 0.0140
206 FIBROMYALGIA 341 0.0140
207 BREATH SOUNDS ABNORMAL 69 0.0140
208 RALES 81 0.0139
209 CELLULITIS 700 0.0139
210 MIOSIS 111 0.0138
211 TROPONIN INCREASED 105 0.0138
212 SCOLIOSIS 85 0.0137
213 PHARYNGITIS 170 0.0137
214 GRAND MAL CONVULSION 126 0.0136
215 CANDIDA INFECTION 229 0.0135
216 CYSTITIS 430 0.0135
217 ARTHROPOD BITE 100 0.0135
218 LOCALISED INFECTION 326 0.0135
219 SUPRAVENTRICULAR TACHYCARDIA 129 0.0135
220 INFUSION RELATED REACTION 892 0.0134
221 COMPRESSION FRACTURE 72 0.0134
222 MUSCLE SPASTICITY 164 0.0133
223 HYPOVOLAEMIA 78 0.0133
224 TORSADE DE POINTES 104 0.0132
225 ROTATOR CUFF SYNDROME 170 0.0132
226 BRAIN OEDEMA 167 0.0132
227 ECONOMIC PROBLEM 200 0.0132
228 BENIGN PROSTATIC HYPERPLASIA 68 0.0132
229 HYPOTENSION 2640 0.0131
230 LEFT VENTRICULAR DYSFUNCTION 88 0.0131
231 SLEEP APNOEA SYNDROME 250 0.0131
232 APPLICATION SITE RASH 180 0.0131
233 PARALYSIS 187 0.0131
234 JOINT DISLOCATION 138 0.0130
235 APPLICATION SITE PAIN 287 0.0130
236 URINARY TRACT INFECTION 2207 0.0129
237 CONCUSSION 100 0.0129
238 SCAR 220 0.0128
239 SCIATICA 204 0.0128
240 VARICOSE VEIN 66 0.0128
241 SPINAL COMPRESSION FRACTURE 105 0.0127
242 THERAPY PARTIAL RESPONDER 198 0.0127
243 HYPERTONIA 72 0.0126
244 IMPAIRED GASTRIC EMPTYING 171 0.0125
245 CLOSTRIDIUM DIFFICILE COLITIS 133 0.0125
246 INTERVERTEBRAL DISC PROTRUSION 274 0.0125
247 ANAL INCONTINENCE 112 0.0124
248 CARDIOTOXICITY 111 0.0124
249 HYPERCHOLESTEROLAEMIA 120 0.0124
250 ECCHYMOSIS 85 0.0124
251 RENAL CYST 98 0.0123
252 FAILURE TO THRIVE 64 0.0123
253 PREMATURE DELIVERY 196 0.0123
254 ACUTE PULMONARY OEDEMA 69 0.0123
255 HAND FRACTURE 87 0.0123
256 MUSCULOSKELETAL CHEST PAIN 189 0.0122
257 HAEMORRHOIDS 238 0.0122
258 PROCEDURAL PAIN 338 0.0122
259 RENAL TUBULAR NECROSIS 119 0.0121
260 CARDIOMEGALY 149 0.0121
261 HIATUS HERNIA 156 0.0120
262 LIMB INJURY 327 0.0120
263 PREMATURE BABY 362 0.0120
264 PNEUMOTHORAX 190 0.0120
265 MOTOR DYSFUNCTION 122 0.0120
266 DIZZINESS POSTURAL 116 0.0120
267 RESPIRATORY TRACT CONGESTION 190 0.0119
268 ATRIOVENTRICULAR BLOCK COMPLETE 80 0.0119
269 BURSITIS 145 0.0119
270 OXYGEN SATURATION DECREASED 671 0.0119
271 LIGAMENT SPRAIN 118 0.0119
272 JOINT EFFUSION 82 0.0119
273 INABILITY TO AFFORD MEDICATION 118 0.0119
274 RENAL FAILURE 1576 0.0119
275 ILLNESS 1219 0.0118
276 INCONTINENCE 125 0.0118
277 AUTOIMMUNE DISORDER 115 0.0118
278 CARPAL TUNNEL SYNDROME 165 0.0118
279 SINUS CONGESTION 159 0.0118
280 FLANK PAIN 110 0.0117
281 FACIAL PARALYSIS 100 0.0117
282 RESPIRATORY ARREST 323 0.0117
283 JOINT RANGE OF MOTION DECREASED 157 0.0117
284 THERAPY NON-RESPONDER 526 0.0117
285 NERVE COMPRESSION 108 0.0117
286 ESCHERICHIA INFECTION 96 0.0117
287 VITAMIN D DEFICIENCY 113 0.0116
288 CYANOSIS 182 0.0116
289 INJURY 813 0.0116
290 FOOT FRACTURE 219 0.0115
291 DIVERTICULUM 82 0.0115
292 OSTEOPENIA 175 0.0115
293 URINARY RETENTION 384 0.0115
294 TRICUSPID VALVE INCOMPETENCE 91 0.0114
295 SPINAL OPERATION 141 0.0114
296 FACIAL PAIN 102 0.0114
297 IMPAIRED QUALITY OF LIFE 164 0.0114
298 PRODUCT LEAKAGE 64 0.0114
299 PRODUCTIVE COUGH 544 0.0114
300 SMALL INTESTINAL OBSTRUCTION 140 0.0114
301 DIPLOPIA 295 0.0113
302 MUSCLE STRAIN 98 0.0113
303 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 591 0.0113
304 OSTEOMYELITIS 205 0.0113
305 EYELID PTOSIS 115 0.0113
306 NECK PAIN 630 0.0113
307 SENSITIVE SKIN 83 0.0112
308 WALKING AID USER 74 0.0112
309 COVID-19 PNEUMONIA 132 0.0112
310 TACHYPNOEA 152 0.0112
311 ARTERIOSCLEROSIS CORONARY ARTERY 74 0.0112
312 IRON DEFICIENCY ANAEMIA 103 0.0111
313 PAIN IN JAW 316 0.0111
314 WOUND INFECTION 122 0.0111
315 COVID-19 1949 0.0111
316 HEREDITARY ANGIOEDEMA 119 0.0111
317 NO THERAPEUTIC RESPONSE 135 0.0111
318 BACK INJURY 120 0.0110
319 SPINAL PAIN 129 0.0110
320 LYMPHOEDEMA 76 0.0110
321 POOR QUALITY SLEEP 236 0.0110
322 PARAESTHESIA ORAL 158 0.0109
323 UPPER-AIRWAY COUGH SYNDROME 90 0.0109
324 OBSTRUCTIVE AIRWAYS DISORDER 121 0.0109
325 HYPOTHERMIA 110 0.0109
326 ORAL CANDIDIASIS 143 0.0108
327 TACHYCARDIA 960 0.0108
328 DRUG TOXICITY 147 0.0108
329 APPLICATION SITE IRRITATION 134 0.0108
330 ASPIRATION 117 0.0107
331 HYPOALBUMINAEMIA 83 0.0107
332 DYSARTHRIA 401 0.0106
333 MALNUTRITION 119 0.0106
334 SEDATION 277 0.0106
335 BRAIN INJURY 106 0.0106
336 PULMONARY HYPERTENSION 220 0.0106
337 BODY TEMPERATURE INCREASED 215 0.0105
338 EXPOSURE DURING PREGNANCY 653 0.0105
339 POST-TRAUMATIC STRESS DISORDER 70 0.0104
340 FUNGAL INFECTION 348 0.0104
341 SEROTONIN SYNDROME 200 0.0104
342 LYMPHOCYTE COUNT DECREASED 183 0.0103
343 SPINAL DISORDER 98 0.0103
344 JOINT INJURY 221 0.0103
345 MASS 144 0.0103
346 BLOOD ALBUMIN DECREASED 81 0.0102
347 HERPES ZOSTER 586 0.0102
348 COMPLICATION ASSOCIATED WITH DEVICE 148 0.0102
349 LUNG INFILTRATION 90 0.0102
350 RESPIRATORY DISTRESS 281 0.0102
351 MUSCULOSKELETAL DISCOMFORT 175 0.0102
352 TOXICITY TO VARIOUS AGENTS 1700 0.0101
353 MITRAL VALVE INCOMPETENCE 114 0.0101
354 PNEUMONIA BACTERIAL 92 0.0100
355 PULMONARY MASS 149 0.0100
356 OEDEMA 541 0.0100
357 INFLUENZA 1112 0.0100
358 DYSPNOEA EXERTIONAL 375 0.0099
359 MULTIPLE ORGAN DYSFUNCTION SYNDROME 282 0.0099
360 OSTEOARTHRITIS 422 0.0099
361 FEBRILE NEUTROPENIA 658 0.0099
362 ACCIDENT 118 0.0099
363 BRAIN FOG 154 0.0098
364 GOUT 176 0.0098
365 PULMONARY CONGESTION 129 0.0098
366 BLOOD PRESSURE DECREASED 650 0.0098
367 PNEUMONIA 3148 0.0097
368 MIGRAINE 928 0.0097
369 CONTUSION 932 0.0097
370 DEVICE PHYSICAL PROPERTY ISSUE 74 0.0096
371 BACK PAIN 2235 0.0096
372 DEVICE RELATED INFECTION 148 0.0096
373 PURPURA 85 0.0096
374 APPLICATION SITE ERYTHEMA 251 0.0096
375 MICTURITION URGENCY 109 0.0095
376 HYPOKALAEMIA 440 0.0095
377 ANKLE FRACTURE 147 0.0095
378 EYE MOVEMENT DISORDER 65 0.0095
379 PRODUCT AVAILABILITY ISSUE 216 0.0095
380 PNEUMONIA ASPIRATION 237 0.0095
381 URINARY INCONTINENCE 281 0.0095
382 HAEMATOCRIT DECREASED 188 0.0095
383 IRRITABLE BOWEL SYNDROME 203 0.0095
384 UNEVALUABLE EVENT 715 0.0094
385 ENCEPHALOPATHY 232 0.0094
386 BACTERAEMIA 112 0.0094
387 RHINITIS 76 0.0094
388 DRUG LEVEL INCREASED 156 0.0094
389 HYPOTONIA 94 0.0094
390 EAR PAIN 183 0.0094
391 RESPIRATORY FAILURE 685 0.0094
392 ULCER 149 0.0094
393 RENAL FAILURE CHRONIC 72 0.0094
394 GROIN PAIN 82 0.0093
395 DELIRIUM 324 0.0093
396 PLEURAL EFFUSION 568 0.0093
397 HOSPICE CARE 92 0.0093
398 RETINAL HAEMORRHAGE 66 0.0093
399 BLADDER DISORDER 92 0.0093
400 SEPSIS 1033 0.0093
401 CARDIO-RESPIRATORY ARREST 387 0.0092
402 BLOOD PRESSURE ABNORMAL 184 0.0092
403 PAIN 5681 0.0092
404 HYPOAESTHESIA 1382 0.0092
405 PALLOR 251 0.0092
406 PULMONARY OEDEMA 413 0.0092
407 DENTAL CARIES 102 0.0092
408 ATAXIA 109 0.0092
409 EXTRASYSTOLES 64 0.0092
410 VITREOUS FLOATERS 90 0.0091
411 INFECTION 1313 0.0091
412 BLOOD CALCIUM DECREASED 102 0.0091
413 MAJOR DEPRESSION 66 0.0090
414 HAEMATOMA 233 0.0090
415 PELVIC FRACTURE 70 0.0090
416 CLOSTRIDIUM DIFFICILE INFECTION 196 0.0090
417 APHONIA 125 0.0089
418 DEPRESSED LEVEL OF CONSCIOUSNESS 353 0.0089
419 BACK DISORDER 145 0.0089
420 BLOOD CALCIUM INCREASED 78 0.0089
421 SPUTUM DISCOLOURED 84 0.0088
422 NASOPHARYNGITIS 1632 0.0088
423 OSTEOPOROSIS 364 0.0088
424 SEIZURE 1019 0.0088
425 BLOOD MAGNESIUM DECREASED 76 0.0088
426 PHARYNGEAL SWELLING 86 0.0088
427 NEPHROPATHY 82 0.0088
428 UROSEPSIS 81 0.0088
429 CONJUNCTIVITIS 162 0.0087
430 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1573 0.0087
431 ACUTE KIDNEY INJURY 1335 0.0087
432 LOSS OF CONSCIOUSNESS 1117 0.0087
433 MATERNAL EXPOSURE DURING PREGNANCY 775 0.0087
434 SPINAL FRACTURE 174 0.0087
435 WRIST FRACTURE 104 0.0087
436 ATRIOVENTRICULAR BLOCK 67 0.0087
437 SWELLING 811 0.0087
438 ORAL PAIN 194 0.0087
439 METABOLIC ACIDOSIS 276 0.0086
440 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 67 0.0086
441 EMPHYSEMA 87 0.0086
442 LEUKOCYTOSIS 156 0.0086
443 CHILLS 1010 0.0086
444 ILEUS 107 0.0086
445 BLOOD UREA INCREASED 144 0.0086
446 DIVERTICULITIS 238 0.0086
447 PRODUCT DOSE OMISSION ISSUE 2525 0.0086
448 BLINDNESS TRANSIENT 63 0.0085
449 ACCIDENTAL OVERDOSE 311 0.0085
450 HYPOMAGNESAEMIA 118 0.0085
451 HEART RATE DECREASED 297 0.0084
452 RESPIRATORY RATE INCREASED 75 0.0084
453 NEPHROLITHIASIS 386 0.0084
454 BLOOD POTASSIUM DECREASED 253 0.0084
455 ORAL HERPES 164 0.0084
456 NEUTROPHIL COUNT INCREASED 86 0.0084
457 TOOTHACHE 152 0.0084
458 SKIN ULCER 217 0.0084
459 HEMIPARESIS 142 0.0084
460 GASTROOESOPHAGEAL REFLUX DISEASE 673 0.0084
461 FALL 2779 0.0083
462 MUSCULAR WEAKNESS 948 0.0083
463 COLD SWEAT 147 0.0083
464 ASCITES 245 0.0083
465 EXPIRED PRODUCT ADMINISTERED 277 0.0083
466 PRODUCT ADMINISTRATION ERROR 168 0.0083
467 SHOCK 191 0.0083
468 HICCUPS 68 0.0083
469 MUSCLE TIGHTNESS 134 0.0083
470 TOOTH FRACTURE 91 0.0082
471 SCRATCH 87 0.0082
472 HEAD INJURY 261 0.0082
473 OESOPHAGITIS 90 0.0082
474 RESPIRATORY DISORDER 246 0.0082
475 ROAD TRAFFIC ACCIDENT 343 0.0082
476 RESTLESS LEGS SYNDROME 148 0.0081
477 LETHARGY 467 0.0081
478 MUSCLE RIGIDITY 97 0.0081
479 BURNING SENSATION 568 0.0081
480 DISABILITY 160 0.0081
481 CARDIAC MURMUR 70 0.0081
482 CATARACT 481 0.0081
483 ATRIAL FIBRILLATION 784 0.0080
484 TOOTH DISORDER 179 0.0080
485 MYOSITIS 72 0.0080
486 IMPAIRED HEALING 263 0.0080
487 MUSCLE TWITCHING 184 0.0080
488 POST PROCEDURAL HAEMORRHAGE 92 0.0079
489 BONE DISORDER 144 0.0079
490 ABSCESS 126 0.0079
491 ARTERIOSCLEROSIS 74 0.0079
492 BLOOD IRON DECREASED 93 0.0078
493 LACERATION 73 0.0078
494 ELECTROLYTE IMBALANCE 90 0.0077
495 BLOOD SODIUM DECREASED 146 0.0077
496 SECRETION DISCHARGE 97 0.0077
497 TUBULOINTERSTITIAL NEPHRITIS 145 0.0077
498 CAESAREAN SECTION 90 0.0077
499 PULMONARY ARTERIAL HYPERTENSION 112 0.0077
500 BLISTER 434 0.0077
501 OROPHARYNGEAL PAIN 712 0.0077
502 CYTOKINE RELEASE SYNDROME 154 0.0077
503 NODULE 100 0.0077
504 NEUROPATHY PERIPHERAL 727 0.0076
505 MUSCULOSKELETAL PAIN 397 0.0076
506 ANXIETY 2155 0.0076
507 FLUID RETENTION 385 0.0076
508 OEDEMA PERIPHERAL 922 0.0076
509 LOWER RESPIRATORY TRACT INFECTION 344 0.0076
510 HYPONATRAEMIA 426 0.0076
511 HYPERTENSION 1601 0.0076
512 TRANSFUSION 79 0.0075
513 NASAL CONGESTION 442 0.0075
514 PYELONEPHRITIS 65 0.0075
515 LOWER LIMB FRACTURE 144 0.0075
516 HAEMOPTYSIS 209 0.0075
517 FOOT DEFORMITY 83 0.0075
518 APHASIA 226 0.0075
519 DRUG INTERACTION 1183 0.0074
520 EYE INFLAMMATION 71 0.0074
521 HEPATOMEGALY 73 0.0074
522 BLOOD PRESSURE INCREASED 1135 0.0074
523 DISCOMFORT 452 0.0074
524 COUGH 2071 0.0074
525 PULMONARY THROMBOSIS 80 0.0073
526 WOUND 205 0.0073
527 UPPER LIMB FRACTURE 146 0.0073
528 DYSURIA 269 0.0073
529 OROPHARYNGEAL DISCOMFORT 66 0.0073
530 LYMPHADENOPATHY 258 0.0073
531 LUNG INFECTION 113 0.0073
532 WHEEZING 430 0.0072
533 CYST 90 0.0072
534 HIP ARTHROPLASTY 111 0.0072
535 CARDIOMYOPATHY 107 0.0072
536 DEVICE DISLOCATION 314 0.0072
537 HEART RATE INCREASED 715 0.0072
538 MYOCARDIAL ISCHAEMIA 82 0.0072
539 HEADACHE 4515 0.0072
540 LIMB DISCOMFORT 222 0.0072
541 ELECTROCARDIOGRAM QT PROLONGED 258 0.0072
542 PYREXIA 2478 0.0072
543 SOMNOLENCE 1441 0.0071
544 CONSTIPATION 1557 0.0071
545 MOUTH ULCERATION 150 0.0071
546 RENAL FAILURE ACUTE 302 0.0071
547 ARTHRITIS 557 0.0071
548 SUBARACHNOID HAEMORRHAGE 72 0.0071
549 GENERALISED OEDEMA 87 0.0070
550 DEHYDRATION 936 0.0070
551 HALLUCINATION, VISUAL 148 0.0070
552 DERMATITIS ALLERGIC 88 0.0070
553 PRESYNCOPE 170 0.0070
554 PRESCRIBED OVERDOSE 135 0.0070
555 ABDOMINAL DISTENSION 728 0.0070
556 CONFUSIONAL STATE 1127 0.0070
557 COMA 332 0.0070
558 TINNITUS 319 0.0069
559 PERICARDIAL EFFUSION 160 0.0069
560 APPLICATION SITE PRURITUS 157 0.0069
561 TOXIC EPIDERMAL NECROLYSIS 105 0.0069
562 ACUTE RESPIRATORY DISTRESS SYNDROME 122 0.0069
563 STOMATITIS 418 0.0069
564 ASTHMA 777 0.0069
565 DISORIENTATION 272 0.0069
566 PHOTOPHOBIA 129 0.0069
567 QUALITY OF LIFE DECREASED 92 0.0069
568 RED BLOOD CELL COUNT DECREASED 196 0.0068
569 NO ADVERSE EVENT 1240 0.0068
570 OBESITY 109 0.0068
571 CHEST PAIN 1263 0.0068
572 RESTLESSNESS 249 0.0068
573 SYNCOPE 680 0.0068
574 RENAL PAIN 72 0.0068
575 INCORRECT PRODUCT ADMINISTRATION DURATION 147 0.0068
576 COAGULOPATHY 113 0.0068
577 OCULAR DISCOMFORT 76 0.0068
578 ADRENAL INSUFFICIENCY 82 0.0068
579 EJECTION FRACTION DECREASED 105 0.0067
580 ERYTHEMA MULTIFORME 63 0.0067
581 PAIN IN EXTREMITY 1988 0.0067
582 CHEST DISCOMFORT 689 0.0067
583 WEIGHT DECREASED 1878 0.0067
584 TENDONITIS 104 0.0067
585 SKIN DISORDER 224 0.0067
586 FULL BLOOD COUNT ABNORMAL 71 0.0067
587 OFF LABEL USE 5868 0.0067
588 EPISTAXIS 501 0.0067
589 GASTRITIS 176 0.0067
590 PERIPHERAL SWELLING 1028 0.0067
591 SWOLLEN TONGUE 208 0.0067
592 AGITATION 488 0.0066
593 HYPERHIDROSIS 855 0.0066
594 EATING DISORDER 141 0.0066
595 SEPTIC SHOCK 288 0.0066
596 VOMITING 3110 0.0066
597 PRODUCT USE IN UNAPPROVED INDICATION 1638 0.0066
598 BLOOD CHOLESTEROL INCREASED 308 0.0066
599 DISSEMINATED INTRAVASCULAR COAGULATION 93 0.0066
600 NERVOUS SYSTEM DISORDER 206 0.0066
601 ANAEMIA 1252 0.0066
602 GASTROINTESTINAL DISORDER 588 0.0066
603 DRY MOUTH 531 0.0065
604 WHITE BLOOD CELL COUNT INCREASED 251 0.0065
605 DYSPNOEA 3684 0.0065
606 INTENTIONAL PRODUCT USE ISSUE 570 0.0065
607 DYSPHAGIA 617 0.0065
608 HYPOCALCAEMIA 123 0.0065
609 DYSKINESIA 264 0.0065
610 NAUSEA 5140 0.0065
611 SCAB 74 0.0065
612 MUSCLE ATROPHY 82 0.0065
613 HYPERTENSIVE CRISIS 72 0.0065
614 DYSPHONIA 378 0.0065
615 TRANSIENT ISCHAEMIC ATTACK 218 0.0065
616 HYPERKALAEMIA 226 0.0064
617 SKIN DISCOLOURATION 296 0.0064
618 LIVER FUNCTION TEST INCREASED 138 0.0064
619 HYPOTHYROIDISM 205 0.0064
620 INFLUENZA LIKE ILLNESS 528 0.0064
621 HERNIA 124 0.0064
622 PRODUCT USE ISSUE 1205 0.0064
623 THROMBOSIS 515 0.0064
624 VERTIGO 390 0.0064
625 BEDRIDDEN 84 0.0064
626 LIP SWELLING 212 0.0064
627 NIGHT SWEATS 205 0.0064
628 MUSCLE SPASMS 1167 0.0064
629 THYROID DISORDER 98 0.0064
630 NEOPLASM 73 0.0063
631 HYPERSOMNIA 182 0.0063
632 INTRAOCULAR PRESSURE INCREASED 81 0.0063
633 SPEECH DISORDER 332 0.0063
634 BLOOD TEST ABNORMAL 89 0.0063
635 DYSTONIA 122 0.0063
636 RETCHING 134 0.0063
637 BASAL CELL CARCINOMA 98 0.0063
638 HEPATIC STEATOSIS 117 0.0063
639 PARAESTHESIA 987 0.0063
640 FATIGUE 4883 0.0063
641 BLOOD URINE PRESENT 119 0.0063
642 EMOTIONAL DISTRESS 758 0.0063
643 SURGERY 367 0.0063
644 JOINT STIFFNESS 164 0.0062
645 PULMONARY EMBOLISM 593 0.0062
646 EAR DISCOMFORT 64 0.0062
647 LUNG DISORDER 305 0.0062
648 RHINORRHOEA 402 0.0062
649 GALLBLADDER DISORDER 111 0.0062
650 CHOLECYSTECTOMY 71 0.0062
651 TREMOR 1028 0.0062
652 FEELING COLD 172 0.0062
653 GAIT INABILITY 206 0.0062
654 IMPAIRED DRIVING ABILITY 70 0.0062
655 CHROMATURIA 139 0.0062
656 BALANCE DISORDER 532 0.0061
657 MUCOSAL INFLAMMATION 161 0.0061
658 HIP FRACTURE 197 0.0061
659 BLOOD POTASSIUM INCREASED 99 0.0061
660 ALTERED STATE OF CONSCIOUSNESS 132 0.0061
661 IMPAIRED WORK ABILITY 130 0.0061
662 TENDON RUPTURE 75 0.0061
663 DRUG EFFECT LESS THAN EXPECTED 90 0.0061
664 SLEEP DISORDER 428 0.0061
665 HEART RATE IRREGULAR 137 0.0061
666 TASTE DISORDER 123 0.0061
667 HYPOKINESIA 88 0.0061
668 NEEDLE ISSUE 176 0.0060
669 MEDICATION ERROR 336 0.0060
670 GLAUCOMA 116 0.0060
671 SUBDURAL HAEMATOMA 86 0.0060
672 ARRHYTHMIA 284 0.0060
673 EYE PAIN 338 0.0060
674 SENSORY DISTURBANCE 96 0.0060
675 DIZZINESS 2981 0.0060
676 URTICARIA 997 0.0059
677 PULMONARY FIBROSIS 114 0.0059
678 DEEP VEIN THROMBOSIS 386 0.0059
679 ACUTE MYOCARDIAL INFARCTION 173 0.0059
680 DYSSTASIA 171 0.0059
681 ERYTHEMA 1203 0.0058
682 BLOOD PRESSURE FLUCTUATION 140 0.0058
683 SWELLING FACE 379 0.0058
684 POISONING 73 0.0058
685 ANGIOEDEMA 257 0.0058
686 ACTIVITIES OF DAILY LIVING IMPAIRED 115 0.0058
687 PALPITATIONS 679 0.0058
688 NEUTROPHIL COUNT DECREASED 236 0.0058
689 DECREASED APPETITE 1342 0.0058
690 ABDOMINAL PAIN 1342 0.0058
691 CONVULSION 329 0.0057
692 SNEEZING 129 0.0057
693 GAIT DISTURBANCE 1100 0.0057
694 BONE PAIN 336 0.0057
695 CHOLECYSTITIS 68 0.0057
696 FULL BLOOD COUNT DECREASED 115 0.0057
697 RENAL IMPAIRMENT 479 0.0057
698 COLITIS 216 0.0057
699 MUSCULOSKELETAL STIFFNESS 498 0.0057
700 CHOLELITHIASIS 186 0.0057
701 METASTASES TO BONE 93 0.0057
702 ASPARTATE AMINOTRANSFERASE INCREASED 301 0.0057
703 HYPERSENSITIVITY 1050 0.0057
704 KNEE ARTHROPLASTY 119 0.0056
705 BLOOD PRESSURE SYSTOLIC INCREASED 110 0.0056
706 ASTHENIA 2119 0.0056
707 UNINTENTIONAL MEDICAL DEVICE REMOVAL 65 0.0056
708 PERIPHERAL COLDNESS 77 0.0056
709 BLINDNESS 228 0.0056
710 DEPRESSION 1272 0.0056
711 AMNESIA 363 0.0056
712 ARTHROPATHY 308 0.0055
713 VISUAL ACUITY REDUCED 184 0.0055
714 THROAT TIGHTNESS 149 0.0055
715 DRUG INTOLERANCE 532 0.0055
716 COGNITIVE DISORDER 257 0.0055
717 MENTAL DISORDER 237 0.0054
718 RASH MACULO-PAPULAR 121 0.0054
719 PRODUCT DOSE OMISSION IN ERROR 154 0.0054
720 PLATELET COUNT DECREASED 579 0.0054
721 ARTHRALGIA 2251 0.0054
722 ORTHOSTATIC HYPOTENSION 94 0.0054
723 SKIN LESION 148 0.0054
724 GASTRIC ULCER 102 0.0054
725 BONE DENSITY DECREASED 168 0.0054
726 HYPOPHAGIA 137 0.0054
727 FOETAL EXPOSURE DURING PREGNANCY 435 0.0053
728 INJECTION SITE EXTRAVASATION 66 0.0053
729 HALLUCINATION 401 0.0053
730 IMMUNE SYSTEM DISORDER 70 0.0053
731 WITHDRAWAL SYNDROME 223 0.0053
732 HEAD DISCOMFORT 94 0.0053
733 INSOMNIA 1414 0.0053
734 HAEMOGLOBIN DECREASED 543 0.0053
735 HAEMATURIA 181 0.0053
736 RECTAL HAEMORRHAGE 227 0.0053
737 FEEDING DISORDER 107 0.0053
738 DIABETES MELLITUS 402 0.0053
739 NOCTURIA 64 0.0053
740 DRUG WITHDRAWAL SYNDROME 462 0.0053
741 MENTAL IMPAIRMENT 127 0.0052
742 PERICARDITIS 88 0.0052
743 IMMUNODEFICIENCY 78 0.0052
744 WEIGHT INCREASED 1171 0.0052
745 TOOTH EXTRACTION 65 0.0052
746 C-REACTIVE PROTEIN INCREASED 190 0.0052
747 FEELING HOT 320 0.0052
748 CARDIAC FAILURE CONGESTIVE 418 0.0052
749 RASH PRURITIC 282 0.0052
750 BLOOD ALKALINE PHOSPHATASE INCREASED 129 0.0052
751 SKIN REACTION 73 0.0052
752 INTESTINAL OBSTRUCTION 195 0.0052
753 DEAFNESS 135 0.0052
754 VISION BLURRED 708 0.0052
755 NERVOUSNESS 269 0.0051
756 PHOTOSENSITIVITY REACTION 85 0.0051
757 DRUG INEFFECTIVE 6783 0.0051
758 BLOOD BILIRUBIN INCREASED 139 0.0051
759 OVERDOSE 1110 0.0051
760 MALAISE 2244 0.0051
761 INFLAMMATION 264 0.0051
762 RENAL DISORDER 238 0.0051
763 THROAT IRRITATION 229 0.0051
764 ALANINE AMINOTRANSFERASE INCREASED 313 0.0051
765 DIARRHOEA 3286 0.0051
766 SARS-COV-2 TEST POSITIVE 67 0.0051
767 BLOOD CREATININE INCREASED 331 0.0051
768 METASTASES TO CENTRAL NERVOUS SYSTEM 65 0.0050
769 MOBILITY DECREASED 362 0.0050
770 CORONARY ARTERY DISEASE 152 0.0050
771 DERMATITIS 105 0.0050
772 OSTEONECROSIS OF JAW 124 0.0050
773 RASH PAPULAR 112 0.0050
774 THERAPEUTIC RESPONSE UNEXPECTED 224 0.0050
775 FLUSHING 506 0.0050
776 SKIN CANCER 107 0.0050
777 MYALGIA 843 0.0050
778 FEELING ABNORMAL 1187 0.0049
779 CARDIAC DISORDER 463 0.0049
780 FLUID OVERLOAD 72 0.0049
781 MEMORY IMPAIRMENT 679 0.0049
782 PSYCHOMOTOR HYPERACTIVITY 82 0.0049
783 MUSCULOSKELETAL DISORDER 94 0.0049
784 DYSPEPSIA 485 0.0049
785 TOOTH LOSS 102 0.0049
786 GINGIVAL BLEEDING 67 0.0049
787 INCORRECT ROUTE OF DRUG ADMINISTRATION 175 0.0049
788 RASH 2134 0.0049
789 DISTURBANCE IN ATTENTION 264 0.0049
790 DEVICE LEAKAGE 212 0.0049
791 PRODUCT USE COMPLAINT 77 0.0049
792 INTENTIONAL DOSE OMISSION 139 0.0049
793 COORDINATION ABNORMAL 68 0.0049
794 JOINT SWELLING 588 0.0049
795 WHITE BLOOD CELL COUNT DECREASED 527 0.0049
796 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 233 0.0048
797 INTENTIONAL PRODUCT MISUSE 424 0.0048
798 PNEUMONITIS 131 0.0048
799 PANCYTOPENIA 268 0.0048
800 PELVIC PAIN 87 0.0048
801 POLLAKIURIA 199 0.0048
802 PARANOIA 82 0.0048
803 CONDITION AGGRAVATED 1446 0.0048
804 ORAL DISCOMFORT 66 0.0047
805 FACE OEDEMA 80 0.0047
806 PLASMA CELL MYELOMA 185 0.0047
807 PRURITUS 1821 0.0047
808 RASH ERYTHEMATOUS 225 0.0047
809 DELUSION 73 0.0047
810 PREGNANCY 94 0.0047
811 PANIC ATTACK 171 0.0047
812 ABDOMINAL DISCOMFORT 786 0.0047
813 PRODUCT PRESCRIBING ISSUE 102 0.0047
814 RASH MACULAR 163 0.0047
815 CENTRAL NERVOUS SYSTEM LESION 64 0.0047
816 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 331 0.0046
817 THERAPEUTIC RESPONSE DECREASED 282 0.0046
818 HAEMORRHAGE 486 0.0046
819 ANGINA PECTORIS 133 0.0046
820 BLOOD TRIGLYCERIDES INCREASED 81 0.0046
821 UPPER GASTROINTESTINAL HAEMORRHAGE 77 0.0046
822 LACRIMATION INCREASED 138 0.0046
823 THERAPEUTIC PRODUCT EFFECT DECREASED 204 0.0046
824 LOCAL SWELLING 79 0.0045
825 DRUG EFFECT DECREASED 242 0.0045
826 HYPERTHYROIDISM 65 0.0045
827 SYSTEMIC LUPUS ERYTHEMATOSUS 159 0.0045
828 DEVICE ISSUE 401 0.0045
829 HEPATIC CIRRHOSIS 84 0.0045
830 MOVEMENT DISORDER 143 0.0044
831 SKIN HAEMORRHAGE 66 0.0044
832 DRY EYE 221 0.0044
833 DRUG ABUSE 365 0.0044
834 SYNOVITIS 79 0.0044
835 THROMBOCYTOPENIA 487 0.0044
836 ADVERSE DRUG REACTION 388 0.0043
837 ABDOMINAL PAIN UPPER 881 0.0043
838 TREATMENT FAILURE 354 0.0043
839 INCORRECT DRUG ADMINISTRATION DURATION 120 0.0043
840 MULTIPLE FRACTURES 70 0.0043
841 HOSPITALISATION 653 0.0042
842 GASTROINTESTINAL HAEMORRHAGE 354 0.0042
843 PRODUCT PREPARATION ERROR 87 0.0042
844 ABASIA 104 0.0042
845 HYPOACUSIS 181 0.0042
846 VISUAL IMPAIRMENT 518 0.0042
847 CARDIAC FAILURE 333 0.0041
848 GENERAL PHYSICAL HEALTH DETERIORATION 479 0.0041
849 STEVENS-JOHNSON SYNDROME 92 0.0041
850 WRONG TECHNIQUE IN DRUG USAGE PROCESS 150 0.0041
851 FLATULENCE 234 0.0041
852 TYPE 2 DIABETES MELLITUS 138 0.0041
853 HYPERGLYCAEMIA 149 0.0041
854 OSTEONECROSIS 134 0.0041
855 CEREBROVASCULAR ACCIDENT 691 0.0041
856 CRYING 148 0.0041
857 INTERNATIONAL NORMALISED RATIO INCREASED 116 0.0041
858 DYSGEUSIA 302 0.0041
859 DEMENTIA 113 0.0040
860 FEELING JITTERY 77 0.0040
861 HAEMATEMESIS 102 0.0040
862 MIDDLE INSOMNIA 75 0.0040
863 EYE DISORDER 132 0.0040
864 DRUG ERUPTION 71 0.0040
865 THINKING ABNORMAL 74 0.0040
866 PRODUCT PHYSICAL ISSUE 80 0.0040
867 EYE SWELLING 147 0.0039
868 HOT FLUSH 297 0.0039
869 GLOSSODYNIA 88 0.0039
870 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 793 0.0039
871 SUICIDAL IDEATION 358 0.0039
872 FEMUR FRACTURE 121 0.0039
873 RHEUMATOID ARTHRITIS 440 0.0039
874 THIRST 69 0.0039
875 THERAPEUTIC RESPONSE SHORTENED 127 0.0038
876 DEVICE MALFUNCTION 269 0.0038
877 EXTRA DOSE ADMINISTERED 155 0.0038
878 TRANSAMINASES INCREASED 85 0.0038
879 CHOKING 74 0.0038
880 FAECES DISCOLOURED 82 0.0038
881 RHABDOMYOLYSIS 157 0.0038
882 DRUG ADMINISTRATION ERROR 113 0.0037
883 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 67 0.0037
884 AGEUSIA 91 0.0036
885 LIVER INJURY 89 0.0036
886 NEUTROPENIA 492 0.0036
887 LIVER DISORDER 160 0.0036
888 EMOTIONAL DISORDER 111 0.0036
889 DEPRESSED MOOD 190 0.0036
890 MOOD ALTERED 98 0.0036
891 THERAPY INTERRUPTED 256 0.0036
892 MALIGNANT NEOPLASM PROGRESSION 366 0.0036
893 EPILEPSY 108 0.0035
894 HYPOGLYCAEMIA 171 0.0035
895 DISEASE PROGRESSION 415 0.0035
896 INJECTION SITE SWELLING 267 0.0035
897 HEPATIC FAILURE 105 0.0035
898 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 81 0.0035
899 DRUG EXPOSURE DURING PREGNANCY 118 0.0035
900 PSYCHOTIC DISORDER 102 0.0035
901 HAEMATOCHEZIA 190 0.0034
902 HEPATIC ENZYME INCREASED 234 0.0034
903 DEVICE USE ERROR 119 0.0034
904 ALOPECIA 669 0.0034
905 OCULAR HYPERAEMIA 161 0.0034
906 LABORATORY TEST ABNORMAL 100 0.0034
907 TREATMENT NONCOMPLIANCE 185 0.0034
908 MELAENA 74 0.0034
909 NIGHTMARE 116 0.0033
910 INCREASED APPETITE 64 0.0033
911 NEOPLASM MALIGNANT 223 0.0033
912 NEOPLASM PROGRESSION 116 0.0033
913 PRURITUS GENERALISED 72 0.0033
914 FRACTURE 63 0.0033
915 INJECTION SITE MASS 123 0.0033
916 GASTRIC DISORDER 114 0.0033
917 LEUKOPENIA 165 0.0033
918 BLOOD CREATINE PHOSPHOKINASE INCREASED 94 0.0033
919 ABDOMINAL PAIN LOWER 82 0.0032
920 IRRITABILITY 195 0.0032
921 SKIN IRRITATION 148 0.0032
922 BLOOD GLUCOSE DECREASED 155 0.0032
923 SKIN EXFOLIATION 272 0.0032
924 PANCREATITIS 170 0.0032
925 CONTRAINDICATED PRODUCT ADMINISTERED 97 0.0032
926 DRUG EFFECT INCOMPLETE 116 0.0032
927 CEREBRAL HAEMORRHAGE 114 0.0032
928 PSORIATIC ARTHROPATHY 129 0.0032
929 INJECTION SITE PAIN 963 0.0031
930 EYE IRRITATION 179 0.0031
931 LIVER FUNCTION TEST ABNORMAL 90 0.0031
932 ECZEMA 161 0.0031
933 EXTRAPYRAMIDAL DISORDER 76 0.0031
934 ABNORMAL BEHAVIOUR 121 0.0031
935 INJECTION SITE ERYTHEMA 377 0.0030
936 ILL-DEFINED DISORDER 182 0.0030
937 CEREBRAL INFARCTION 73 0.0030
938 PHARMACEUTICAL PRODUCT COMPLAINT 76 0.0029
939 DEATH 2513 0.0029
940 INCORRECT DOSE ADMINISTERED 664 0.0029
941 MULTIPLE SCLEROSIS 139 0.0029
942 ABNORMAL DREAMS 80 0.0029
943 INTENTIONAL OVERDOSE 185 0.0029
944 FREQUENT BOWEL MOVEMENTS 77 0.0028
945 MYOCARDIAL INFARCTION 497 0.0028
946 INJECTION SITE PRURITUS 190 0.0028
947 EYE PRURITUS 95 0.0028
948 PAIN OF SKIN 76 0.0028
949 INJECTION SITE REACTION 194 0.0028
950 CARDIOVASCULAR DISORDER 71 0.0028
951 AGGRESSION 137 0.0027
952 RASH GENERALISED 70 0.0027
953 INJECTION SITE BRUISING 215 0.0027
954 DRUG-INDUCED LIVER INJURY 84 0.0027
955 PRODUCT SUBSTITUTION ISSUE 154 0.0027
956 PRODUCT DOSE OMISSION 174 0.0027
957 LACTIC ACIDOSIS 85 0.0026
958 DEVICE BREAKAGE 106 0.0026
959 HEPATIC FUNCTION ABNORMAL 97 0.0026
960 ADVERSE EVENT 235 0.0025
961 ACCIDENTAL EXPOSURE TO PRODUCT 262 0.0025
962 MOOD SWINGS 81 0.0025
963 HEPATITIS 65 0.0025
964 VAGINAL HAEMORRHAGE 109 0.0025
965 DRY SKIN 333 0.0025
966 JAUNDICE 67 0.0025
967 THERAPY CESSATION 124 0.0024
968 TARDIVE DYSKINESIA 68 0.0024
969 BLOOD GLUCOSE INCREASED 454 0.0024
970 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 68 0.0023
971 MULTIPLE SCLEROSIS RELAPSE 157 0.0023
972 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 162 0.0023
973 ANGER 77 0.0023
974 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 73 0.0022
975 INTERSTITIAL LUNG DISEASE 104 0.0021
976 DEVICE DIFFICULT TO USE 142 0.0021
977 INJECTION SITE RASH 65 0.0021
978 COMPLETED SUICIDE 175 0.0021
979 SKIN BURNING SENSATION 150 0.0021
980 SUICIDE ATTEMPT 125 0.0021
981 LUNG NEOPLASM MALIGNANT 82 0.0020
982 UNDERDOSE 140 0.0019
983 INJECTION SITE HAEMORRHAGE 148 0.0019
984 DRUG DOSE OMISSION 303 0.0018
985 DRUG DEPENDENCE 288 0.0018
986 COLITIS ULCERATIVE 80 0.0018
987 DISEASE RECURRENCE 85 0.0018
988 PSORIASIS 231 0.0018
989 BREAST CANCER 135 0.0014
990 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 67 0.0014
991 ACNE 105 0.0014
992 DERMATITIS ATOPIC 72 0.0014
993 PRODUCT STORAGE ERROR 106 0.0012